Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

Home

XOMA

X

XOMA Royalty Corporation (XOMA)

NGM – Real Time Price. Currency in USD

30.17

-0.36 (-1.18%)

At close: Mar 27, 2026, 4:00 PM EDT

30.17

0.00 (0.00%)

After-hours: Mar 27, 2026, 4:20 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty's Series A and Series B Cumulative Preferred Stock: Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share.

XOMA Royalty Corporation (XOMA) Q4 2025 Earnings Call Transcript

XOMA Royalty Corporation (XOMA) Q4 2025 Earnings Call Transcript

XOMA Royalty Corporation (XOMA) Q4 2025 Earnings Call Transcript

XOMA Royalty Jumps After Q4 Double Beat, Signals Pipeline Catalysts Ahead

XOMA Royalty Jumps After Q4 Double Beat, Signals Pipeline Catalysts Ahead

XOMA Royalty Corporation (NASDAQ: XOMA) shares are trading higher Wednesday after the company reported fourth-quarter financial results.

XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements

XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements

Portfolio receipts : • Achieved over $50 million of cash receipts, including $33.6 million in royalties and $16.9 million milestones, in full year 2025 • Total receipts increased 9% with royalties up 68% versus full year 2024

XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

EMERYVILLE, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty announced today it will report fourth quarter and full year 2025 financial results on Wednesday, March 18.

XOMA Royalty: Preferreds Still Offer Compelling Income Despite Call Risk

XOMA Royalty: Preferreds Still Offer Compelling Income Despite Call Risk

XOMAO is XOMA Royalty Corporation's 8.375% cumulative preferred. I believe the core thesis centers on their dividend durability at this point. In my view, this means that as long as XOMA keeps a healthy balance sheet and its yield remains compelling, then XOMAO looks like a viable dividend play. In that sense, XOMA added 24 assets in 2025. They continue aggregating royalty interests, corporate deals, and contracts.

XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.

XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.

EMERYVILLE, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company successfully completed its previously announced tender offer to acquire all outstanding shares of Generation Bio Co. (NASDAQ: GBIO) (“Generation Bio”) common stock for a price per share of $4.2913 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR”) (together with the Cash Amount, the “Offer Price”) and successfully completed its acquisition of Generation Bio.

Videos

No Data

There is no data to display